TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT03881293

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: lidocaine 2% gel
Description: Transurethral instillation of 5 ml lidocaine 2% gel

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: water soluble lubricant
Description: Transurethral instillation of 5 ml water soluble lubricant
Study: NCT03087500

Intervention type: OTHER
Intervention: There is no other intervention, only clinical treatment.
Description: There is no other intervention, only clinical treatment.

Intervention type: OTHER
Intervention: There is no other intervention, only clinical treatment.
Description: There is no other intervention, only clinical treatment.
Study: NCT03362814

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ravidasvir
Description: Ravidasvir 200mg tablet administered orally once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danoprevir
Description: Danoprevir 100mg tablet administered orally twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Description: Ritonavir 100mg tablet administered orally twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ribavirin 100 MG
Description: Ribavirin tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations(\<75kg = 1000mg and ≥75kg = 1200mg)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ravidasvir Placebo
Description: Ravidasvir Placebo tablet administered orally once daily
Study: NCT03054649

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HARMONI® Modular Intraocular Lens System
Description: Two-component system consisting of a base and a separate optic that allows for an intraoperative exchange of the optic only without direct manipulation of the capsular bag

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intraoperative optic exchange
Description: Removal of one optic and replacement with another during cataract surgery for the purpose of improving refractive outcomes
Study: NCT03852667

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pain Neuroscience Education
Description: The PNE intervention consisted of 2 sessions of 30 minutes. In the first session, the main goal is to explain the patient why pain is important and why people can't live without it. Besides it is explained why objective findings such as x-rays, MRI, CT scans, etc. often lack significant findings despite the pain that the patient experiences. This first session of pain education might help the patient understand that pain is necessarily a result from tissue damage. Furthermore, the session explains the right approach to conquer pain and to avoid going down in this vicious circle of low back pain. The second session of PNE, is a revision of the first session, continuing on what was unclear from the first session.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pain Neuroscience Education
Description: The PNE intervention consisted of 2 sessions of 30 minutes. In the first session, the main goal is to explain the patient why pain is important and why people can't live without it. Besides it is explained why objective findings such as x-rays, MRI, CT scans, etc. often lack significant findings despite the pain that the patient experiences. This first session of pain education might help the patient understand that pain is necessarily a result from tissue damage. Furthermore, the session explains the right approach to conquer pain and to avoid going down in this vicious circle of low back pain. The second session of PNE, is a revision of the first session, continuing on what was unclear from the first session.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise therapy
Description: The exercise therapy varies form analytical exercises in the first sessions, to functional and sports related exercises near the following sessions. The first session focuses on the lumbar neuromuscular control of the patients: first a voluntary contraction of the Transversus Abdominis muscle, the Multifidus muscle and the pelvic floor muscles is learned. When the subject is able to maintain the combined contraction for 10 times, the exercises evolve to more complicated tasks. In the final stage, more functional and sport specific tasks will be exercised.
Study: NCT00275067

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: arsenic trioxide
Description: Arsenic trioxide administered intravenously at a dose of 0.20mg/kg Daily x 5 week then twice per week

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: temozolomide
Description: Temozolomide administered orally once per day 1 hour prior to radiation therapy at a dose of 75 mg/m2 x 42 days; at a dose of 200mg/m2 for 5 days every cycle (1 cycle = 28 days) after radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Description: All patients will receive 5940-6120 cGy of radiation therapy as 28-33 treatments/fractions (180-200 cGy/treatment) depending on whether they receive standard 3-D conformal radiation therapy or intensity modulated radiation therapy.
Study: NCT04131465

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Home HIV rapid testing
Description: Offer of HIV rapid testing with Alere Determine HIV-1/2

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Home HIV self-testing and rapid testing
Description: Offer of 3 OraQuick HIV self-test kits and HIV rapid testing with Alere Determine HIV-1/2
Study: NCT03100604

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: desflurane,
Description: Patients were divided into two groups according to inhalation agent administered for the surgery; Sevofluran, Group S (n=25) and Desfluran, Group D (N=25).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Description: For a drug, use generic name if established. Use the same name as in the associated Arm/Group Description(s).
Study: NCT02923856

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The results of clarithromycin susceptibility test of H. pylori isolates
Description: According to the results of antibiotic susceptible testing, patients who were resistant to clarithromycin were belonged into clarithromycin resistance group.Patients who were sensitive to clarithromycin were belonged into the 7days/10days/14days treatment groups.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The results of clarithromycin susceptibility test of H. pylori isolates
Description: According to the results of antibiotic susceptible testing, patients who were resistant to clarithromycin were belonged into clarithromycin resistance group.Patients who were sensitive to clarithromycin were belonged into the 7days/10days/14days treatment groups.
Study: NCT04058847

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Your Heart Forecast
Description: 1 year follow up with Your Heart Forecast and a follow-up email every 2 weeks.
Study: NCT02022228

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: triptorelin
Description: 0.2 mg triptorelin, ih

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: triptorelin
Description: 0.2 mg triptorelin, ih

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hCG
Description: 1000 IU hCG, im

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: hCG
Description: 500IU hCG, im
Study: NCT01388946

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine 0.75

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Study: NCT03799198

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Weight Management Program (WMP)
Description: As part of usual care, participants will: 1) Discuss and choose one of three diet options: protein-sparing modified fast, Mediterranean, or meal replacement. 2) Be referred to a nutritionist appointment. 3) Initiate a series of twelve monthly study visits in the context of shared medical appointments (SMAs) covering nutrition, physical activity, appetite control, sleep issues, and anxiety/depression/stress. 4) Be referred to an exercise physiologist for a personalized physical activity program. 5) If assessed relevant by the study clinician, be referred to a mental health specialist and/or sleep clinic.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Weight Management Program (WMP)
Description: As part of usual care, participants will: 1) Discuss and choose one of three diet options: protein-sparing modified fast, Mediterranean, or meal replacement. 2) Be referred to a nutritionist appointment. 3) Initiate a series of twelve monthly study visits in the context of shared medical appointments (SMAs) covering nutrition, physical activity, appetite control, sleep issues, and anxiety/depression/stress. 4) Be referred to an exercise physiologist for a personalized physical activity program. 5) If assessed relevant by the study clinician, be referred to a mental health specialist and/or sleep clinic.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Medication for chronic weight management (Rx)
Description: Following listed 5 drugs will be administered as prescribed by the study doctor:~1) Orlistat (Xenical® pills, per os \[p.o.; by mouth\]). 2) Lorcaserin or lorcaserin extended-release (Belviq®/Belviq XR® pills, p.o.). 3) Phentermine/topiramate extended-release (Qsymia® pills, p.o.). 4) Naltrexone/bupropion extended-release (Contrave® pills, p.o.). 5) Liraglutide 3.0 mg (Saxenda® injections, subcutaneously \[under the skin\]).
Study: NCT03344029

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SP Shz TIV
Description: 0.5 mL, intramuscular into the deltoid muscle, single injection on Day 0

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Hualan TIV
Description: 0.5 mL, intramuscular into the deltoid muscle, single injection on Day 0
Study: NCT03707106

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CBT smoking cessation
Description: an established protocol for smoking cessation based on cognitive behavioral therapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CBT smoking cessation
Description: an established protocol for smoking cessation based on cognitive behavioral therapy

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: virtual reality based cue exposure
Description: smoking cue exposure in virtual reality

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: progressive muscle relaxation
Description: Progressive muscle relaxation for unspecific stress reduction
Study: NCT03247608

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ambio Health Remote Monitoring
Description: Participants in the Connected Heart Health study will complete a 24 week CarePlan including education, biometric monitoring, and communication with the health care team members. Each day the participant will receive an email from Ambio Health with a daily task list that includes a variety of activities. These tasks include uploading biometrics (weight and blood pressure), completing assessment on self-management skills (nutrition, physical activity, and medication management), accessing educational content (videos, web links, interactive quizzes), participation in challenges, and communicating with the care team and care givers.
Study: NCT03805763

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Large extent of ILM Peeling
Description: The extent of ILM peeling is 4DD

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Small extent of ILM Peeling
Description: The extent of ILM peeling is 2DD
Study: NCT02696382

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive High Intensity Therapy (PHIT)
Description: Participants in the Progressive High Intensity Therapy (PHIT) group will receive high intensity physical therapy following discharge from acute hospitalization. The activities of training will include progressive resistance training, multi-planar motor control and gait exercises, and high intensity activities of daily living training. Like the Usual Care group, the PHIT participants will receive 12 intervention visits over 4 weeks (3 visits per week). Participants will also receive a standardized home exercise program.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care (UC)
Description: Participants in the Usual Care group will receive standard physical therapy following discharge from acute hospitalization. The activities of therapy will include basic strength training, single-planar motor control and gait exercises, and activities of daily living training. Participants will receive 12 intervention visits over 4 weeks (3 visits per week). Participants will also receive a standardized home exercise program.
Study: NCT01447069

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Salbutamol
Description: The initial dose will be 0.5mg bid, with acceleration of the dose every two weeks by 1mg, up to a maximal dose of 2mg bid or an increase in heart rate by 50% above the baseline heart rate, as long as it remains \<100 bpm
Study: NCT00694226

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: brief motivational intervention
Description: Brief intervention, consisting in an intervention with the adolescent and a session with parents or mentors. The session with the adolescent lasted 60 minutes. Materials related to the interview were developed according to previous reports on the subject. After building a good rapport the interviewer involved the patient in an initial discussion about the results of the evaluation. This led to a review of the drugs used by the subject and an elicitation of positives and negatives of drug use. The relationship between drug use and current and long-term goals was explored. Discrepancies and problems in the future related to substance use were examined, and information and counseling was offered. The basic components of the motivational interview approach were contemplated, and several skills were used by the interviewers. The individual session with parents or mentors consisted in the presentation of educational materials and a brief counseling intervention on parenting skills.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: treatment as usual
Description: Treatment as usual (TTU): After completion of the intervention, individuals and their families went on to receive standard care at the Child and Adolescent Psychiatry and Psychology Department according to the primary diagnosis.Individuals assigned to this group and their parents or tutors received standard care and no further intervention other than completion of the assessment protocol.
Study: NCT02096406

Intervention type: DRUG
Group type: OTHER
Intervention: ACE/ARB continuation
Description: ACE/ARB will be taken the morning of surgery with a sip of water

Intervention type: DRUG
Group type: OTHER
Intervention: ACE/ARB withdrawal
Description: ACE/ARB will be stopped 48 hours prior to surgery
Study: NCT01993290

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 20 ml in total of 0,75% Ropivacaine is administered to each patient in all three arms.
Study: NCT01483495

Intervention type: DEVICE
Intervention: Diffuse optical spectroscopy
Description: Diffuse Optical Spectroscopy Imaging Cerebrovascular Reactivity
Study: NCT03929549

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RCMP titration
Description: An overnight titration polysomnogram with gradual mandibular protrusion and assessment of polysomnographic parameters (i.e. AHI, oxygen saturation, etc.) at various magnitudes of protrusion.
Study: NCT01617161

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Proton Beam Therapy
Description: 5 days per week up to 9 weeks

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity Modulated Radiation Therapy
Description: 5 times per week up to 9 weeks
Study: NCT04114955

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Manas por Manas
Description: Manas for Manas works at both the group- and individual-levels to increase self-care and reduce the negative health impacts of stigma, including: 1) a group-level, peer-led intervention, which first demonstrated efficacy with trans women in the US as 'Sheroes' and has been successfully adapted for Brazil, and 2) an individual-level peer navigation program.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Manas por Manas
Description: Manas for Manas works at both the group- and individual-levels to increase self-care and reduce the negative health impacts of stigma, including: 1) a group-level, peer-led intervention, which first demonstrated efficacy with trans women in the US as 'Sheroes' and has been successfully adapted for Brazil, and 2) an individual-level peer navigation program.
Study: NCT02470325

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Avidekel oil
Description: Avidekel cannabis oil 6:1 CBD:THC
Study: NCT01985555

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Volitinib(HMPL-504)
Description: Volitinib(HMPL-504) is a tablet in the form of 25 mg ,100mg and 200 mg,oral,once daily or 2 times a day.
Study: NCT04312711

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: 3D-TOF-MRA
Description: The Principle of 3D-TOF-MRA is based on the flow effect of MR. In the GE sequence of MRA imaging, the effect of RF pulses makes the protons in the stationary tissue in the active layer in a saturated state, and the longitudinal magnetization disappears. When the inflow blood appears, its protons are in an unsaturated state and have a high degree of longitudinal magnetization. In this way, a clear difference is formed between saturated tissue and unsaturated flowing blood to display blood vessels. 3D-TOF-MRA is a non-invasive and safe method for diagnosing vascular diseases.
Study: NCT00444028

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Loxapine 0.625 mg
Description: Single 0.625 mg (lowest) dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Loxapine 1.25 mg
Description: Single 1.25 mg (2nd) dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Loxapine 2.5 mg
Description: Single 2.5 mg (3rd) dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Loxapine 5 mg
Description: Single 5 mg (4th) dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Loxapine 10 mg
Description: Single 10 mg (5th) dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Placebo (0 mg)
Description: Single placebo dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Placebo (0 mg)
Description: Single placebo dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Placebo (0 mg)
Description: Single placebo dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Placebo (0 mg)
Description: Single placebo dose of inhaled loxapine

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inhaled Placebo (0 mg)
Description: Single placebo dose of inhaled loxapine
Study: NCT01584193

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided subclavian vein puncture
Description: Central venous access port implementation through ultrasound-guided subclavian vein puncture and Seldinger technique

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cephalic vein dissection
Description: Central venous access port implementation through cephalic vein dissection and cutdown
Study: NCT04709640

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tailored Medication Management Intervention
Description: This research study involved an initial 1.5 hour visit and 2-3 follow up home visits (each lasting 60 minutes). Participants received 2-3 home visits during which they received recommendations on strategies which will improve medication management. Level II occupational therapy fieldwork students made the recommendations, after approval from their supervising licensed OT. The OT fieldwork students provided assistance to the individual in implementing strategies, obtaining adaptive equipment at little or no cost to the individual.
Study: NCT02797600

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Questionnaires will be used to obtain self-reported demographic, behavioral, social, family and medical history, and quality of life data. The questions are standardized and taken from either nationally recognized surveys, CARE I surveys, or represent validated survey items.

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Questionnaires will be used to obtain self-reported demographic, behavioral, social, family and medical history, and quality of life data. The questions are standardized and taken from either nationally recognized surveys, CARE I surveys, or represent validated survey items.

Intervention type: BEHAVIORAL
Intervention: Questionnaires
Description: Questionnaires will be used to obtain self-reported demographic, behavioral, social, family and medical history, and quality of life data. The questions are standardized and taken from either nationally recognized surveys, CARE I surveys, or represent validated survey items.

Intervention type: OTHER
Intervention: Biological Samples
Description: All biological samples will be collected at the time of the clinical Pap smear for the controls, and will be collected for the Arm 2 (newly diagnosed) during a scheduled clinic visit. For those individuals in Arm 1, biological samples will be collected during a scheduled visit with the research staff.

Intervention type: OTHER
Intervention: Biological Samples
Description: All biological samples will be collected at the time of the clinical Pap smear for the controls, and will be collected for the Arm 2 (newly diagnosed) during a scheduled clinic visit. For those individuals in Arm 1, biological samples will be collected during a scheduled visit with the research staff.
Study: NCT01440348

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cruciate ligament reconstruction
Description: Multiple cruciate ligament reconstructions with a single Achilles allograft with was divided into two or three strips according to the thickness and length of the allograft.
Study: NCT03876327

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: fecal microbial transplantation
Description: Fecal microbiota transplantation (FMT) is a technique in which intestinal microbiota are transferred from a healthy donor to the patient, with as primary goal to introduce - or restore - a stable and 'healthy' microbial community in the gut.
Study: NCT02797600

Intervention type: OTHER
Intervention: Biological Samples
Description: All biological samples will be collected at the time of the clinical Pap smear for the controls, and will be collected for the Arm 2 (newly diagnosed) during a scheduled clinic visit. For those individuals in Arm 1, biological samples will be collected during a scheduled visit with the research staff.